Manliquez, Eñego C.

HRN: 29-14-83  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/03/2026
CEFTAZIDIME 1GM (VIAL)
07/03/2026
07/10/2026
IV
1g
Q8
Cap Mr Extensive Ptb
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: